Development trends for human monoclonal antibody therapeutics.
Fully human monoclonal antibodies (mAbs) are a promising and rapidly growing category of targeted therapeutic agents. The first such agents were developed during the 1980s, but none achieved clinical or commercial success. Advances in technology to generate the molecules for study - in particular, transgenic mice and yeast or phage display - renewed interest in the development of human mAbs during the 1990s. In 2002, adalimumab became the first human mAb to be approved by the US Food and Drug Administration (FDA). Since then, an additional six human mAbs have received FDA approval: panitumumab, golimumab, canakinumab, ustekinumab, ofatumumab and denosumab. In addition, 3 candidates (raxibacumab, belimumab and ipilimumab) are currently under review by the FDA, 7 are in Phase III studies and 81 are in either Phase I or II studies. Here, we analyse data on 147 human mAbs that have entered clinical study to highlight trends in their development and approval, which may help inform future studies of this class of therapeutic agents.
Nelson
Aaron L
AL
Tufts University School of Medicine, Boston, Massachusetts 02118, USA.
Dhimolea
Eugen
E
Reichert
Janice M
JM
D000068879:Adalimumab; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000639:trends; D017277:Drug Approval; D055808:Drug Discovery / Q000639:trends*; D006801:Humans
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C511911:belimumab; D000068879:Adalimumab
MAbs. 2010 May-Jun;2(3):256-65
20400861
Nature. 1990 Dec 6;348(6301):552-4
2247164
Trends Immunol. 2007 Nov;28(11):482-90
17964218
MAbs. 2009 Jul-Aug;1(4):326-31
20068404
Nature. 1991 Aug 15;352(6336):624-8
1907718
Ann Intern Med. 1994 Jul 1;121(1):58-60
8198349
N Engl J Med. 2009 Jun 4;360(23):2416-25
19494217
J Clin Oncol. 2007 May 1;25(13):1658-64
17470858
Nat Biotechnol. 1996 Mar;14(3):309-14
9630891
J Immunol Methods. 1999 Dec 10;231(1-2):11-23
10648924
Nat Biotechnol. 2007 May;25(5):555-61
17483842
Neurol Sci. 2002 Apr;23 Suppl 1:S1-8
12032582
Proc Natl Acad Sci U S A. 1985 Mar;82(6):1790-4
3856860
Arch Dermatol. 2010 Feb;146(2):127-32
20157022
Nat Genet. 1994 May;7(1):13-21
8075633
J Immunol Methods. 1987 Jun 26;100(1-2):5-40
3298441
N Engl J Med. 2010 Aug 19;363(8):711-23
20525992
Nat Biotechnol. 2005 Sep;23(9):1073-8
16151394
MAbs. 2009 May-Jun;1(3):210-5
20065634
Methods. 2005 May;36(1):3-10
15848070
Arthritis Rheum. 2009 Sep 15;61(9):1168-78
19714604
Nat Rev Drug Discov. 2007 May;6(5):349-56
17431406
Rheumatol Int. 2007 Jan;27(3):269-74
17006705
Arthritis Rheum. 2003 Jan;48(1):35-45
12528101
J Pharm Biomed Anal. 2010 Jan 5;51(1):252-4
19679421
Nat Rev Rheumatol. 2010 Mar;6(3):124-5
20197774
Curr Pharm Biotechnol. 2008 Dec;9(6):423-30
19075682
Nat Rev Drug Discov. 2006 Mar;5(3):191-5
16518372
Proc Natl Acad Sci U S A. 1982 Nov;79(21):6651-5
6292911
Drug Discov Today. 2004 Jan 15;9(2):82-90
15012932
J Immunol. 2006 Jul 1;177(1):362-71
16785532
N Engl J Med. 2003 Feb 13;348(7):601-8
12584368
N Engl J Med. 2008 Mar 13;358(11):1109-17
18337601
MAbs. 2010 Jan-Feb;2(1):84-100
20065640
N Engl J Med. 1991 Feb 14;324(7):429-36
1988827
MAbs. 2010 Jan-Feb;2(1):3-13
20065636
J Clin Invest. 1982 Jul;70(1):205-8
7085884
Mol Immunol. 2007 Sep;44(16):3823-37
17768100
Nat Biotechnol. 2005 Sep;23(9):1117-25
16151405
Ann Intern Med. 1994 Jul 1;121(1):1-5
8198341
J Exp Med. 1984 Feb 1;159(2):537-50
6582214
Ann Rheum Dis. 2007 Jul;66(7):921-6
17301106
Clin Colorectal Cancer. 2006 Jul;6(2):118-24
16945167
MAbs. 2009 Jul-Aug;1(4):332-8
20073133
MAbs. 2009 Nov-Dec;1(6):531-8
20068396
J Immunol. 2007 Jun 1;178(11):7467-72
17513798
MAbs. 2009 Sep-Oct;1(5):422-31
20065639
Cancer Chemother Pharmacol. 2009 May;63(6):1017-22
18781300
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5429-31
6159646
Nature. 1994 Apr 28;368(6474):856-9
8159246
Crit Care Med. 1993 Aug;21(8):1233-41
8339592
MAbs. 2009 May-Jun;1(3):216-21
20069753
Semin Thromb Hemost. 2000;26(2):151-5
10919407
J Immunol. 1981 Oct;127(4):1275-80
6268704